Intrauterine Contraceptive Device (IUCD) Migration to the Urinary Bladder: A Case Report

We highlight a unique case of an intravesical intrauterine contraceptive device (IUCD) that was discovered incidentally in the course of evaluation for secondary infertility in a woman who denied knowledge of insertion of the device. The IUCD was easily retrieved at cystoscopy as a day case procedure.Key Words : Intrauterine Contraceptive Device, Migration, Urinary bladder

Effect of honey consumption on intestinal motility in male albino rats

Summary: This study investigated the effects of honey on intestinal  motility and transit using twenty (20) male albino rats of Wistar strain weighing 210-220g. The rats were randomly grouped into control and  honey-fed (test) groups of ten (10) rats each. The control group was fed on normal rat chow ( Pfizer Company, Nigeria ) and water while the test  group was fed on rat feed, water and honey ( 1 ml of honey to every 10 ml initial drinking water daily) for twenty two (22) weeks after which the rats  were starved over night before the experiment and sacrificed by stunning. Laparatomy was immediately performed, proximal and distal portions of the intestine identified, cut and put in aerated tyrode solution. Cut sections of the ileum (2-3cm) were mounted on organ bath instrument for motility experiment with varying concentrations of acetylcholine and carbachol. Contractions were recorded as well as the intestinal transit in each group and lengths of intestine with total mean values calculated. Results  obtained showed that honey significantly decreased (p<0.01 ) intestinal transit in the test group (21.15±0.75 ) compared with the control group ( 35.96±1.15); decreased intestinal motility in the test group compared with the control and caused significant percentage reduction of intestinal motility with varied concentrations of acetylcholine and carbachol in the test group ( Ach-75.00±0.75%; Carbachol-79.00±0.28%) compared with the control group (Ach-62.00±0.39%; Carbachol-51.00±0.39%). In conclusion,  unprocessed Nigerian honey decreased intestinal transit, caused intestinal smooth muscle inhibition and motility and reduced sensitivity of   gastrointestinal tract to cholinergic agents.Keywords: Honey, Intestinal motility, Intestinal transit, Diarrhoea  treatment

Blood biochemistry and haematology of weaner rabbits fed sun-dried, ensiled, and fermented cassava peel-based diets

Twenty-four New Zealand white × Chinchilla weaner bucks, aged between 7 and 8 weeks and averaging 0.9 kg in weight, were divided into four groups of six each and used in a 12-week feeding trial to evaluate the blood biochemistry and haematology of rabbits fed sun-dried, ensiled, and fermented cassava peel-based diets. The test diets designated A, B, C and D were completely randomised. Diet A, the control, was a 16.18 per cent CP (crude protein) weaner ration formulated from maize, maize offals, soya bean meal, blood meal, oyster shell, bone meal, vitamin premix, and common salt. Diets B, C and D were also weaner rations of, respectively, 16.10, 16.20 and 16.08 per cent CP in which 10 per cent maize of the control diet was replaced, respectively, with sun-dried, ensiled and fermented cassava peels. The diets were roughly iso-caloric. The haematological components of the study included packed cell volume (PCV), white blood cells (WBC), neutrophil (N), and lymphocytes (L). The biochemical parameters were serum creatinine, urea, bilirubin (total and conjugated), serum glutamic transaminase (SGPT), serum glutamic oxaloacetic transaminase (SGOT), eosinophil, and blood sugar. Liver and kidney weights were also monitored. The results showed that PCV, WBC, N and L were affected (P0.05) among rabbits fed different dietary treatments. Vingt-quatre lapins mâles en sevrage de l\'espèce de Nouvelle - Zélande blanc × Chinchilla agé de 7 à 8 semaines et de poids moyen de 0.9 kg étaient divisés en 4 groups de 6 lapins chacun et employés dans un essai d\'alimentation de 12 semaines pour évaluer la biochimie et l\'hématologie de sang de lapins nourris de régimes à base de pelure de manioc séchée de soleil, ensilées et fermentée. Les régimes d\'essai classés A, B, C et D étaient complètement choisis au hasard. Le régime A, le contrôle, était une ration de sevrage avec 16.18% de CP (protéine brute) formulée de maïs, déchets de maïs, farine de graine de soja, farine sanguine, coquille d\'huître, engrais de cendres d\'os, vitamine prémix et sel ordinaire. Les régimes B, C et D étaient aussi des rations de sevrage, respectivement, avec 16.10, 16.20 et 16.08% de CP enquel 10% de maïs du régime de contrôle était remplacé par les pelures de manioc, respectivement, séchée de soleil, ensilées et fermentée. Les régimes étaient approximativement iso-cloriques. Les éléments hématologiques de l\'étude comprenaient la volume de cellule tassée (VCT), le globule sanguin blanc (GSB), le neutrophile (N) et les lymphocytes (L). Les paramètres biochimiques étaient le sérum créatinine, l\'urée, la bilirubine (totale et conjuguée), le sérum glutamique transaminase (SGPT), le sérum glutamique oxaloacétique transaminase (SGOT), l\'éosinophile et le sucre dans le sang. Les poids de foie et de rein étaient également suivis de près. Les résultats montraient que VCT, GSB, les neutrophiles et les lymphocytes étaient modifiés (

Biological sample donation and informed consent for neurobiobanking: Evidence from a community survey in Ghana and Nigeria

Copyright: \ua9 2022 Singh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Introduction Genomic research and neurobiobanking are expanding globally. Empirical evidence on the level of awareness and willingness to donate/share biological samples towards the expansion of neurobiobanking in sub-Saharan Africa is lacking. Aims To ascertain the awareness, perspectives and predictors regarding biological sample donation, sharing and informed consent preferences among community members in Ghana and Nigeria. Methods A questionnaire cross-sectional survey was conducted among randomly selected community members from seven communities in Ghana and Nigeria. Results Of the 1015 respondents with mean age 39.3 years (SD 19.5), about a third had heard of blood donation (37.2%, M: 42.4%, F: 32.0%, p = 0.001) and a quarter were aware of blood sample storage for research (24.5%; M: 29.7%, F: 19.4%, p = 0.151). Two out of ten were willing to donate brain after death (18.8%, M: 22.6%, F: 15.0%, p<0.001). Main reasons for unwillingness to donate brain were; to go back to God complete (46.6%) and lack of knowledge related to brain donation (32.7%). Only a third of the participants were aware of informed consent (31.7%; M: 35.9%, F: 27.5%, p<0.001). Predictors of positive attitude towards biobanking and informed consent were being married, tertiary level education, student status, and belonging to select ethnic groups. Conclusion There is a greater need for research attention in the area of brain banking and informed consent. Improved context-sensitive public education on neurobiobanking and informed consent, in line with the sociocultural diversities, is recommended within the African sub region

Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data

BACKGROUND: Gametocytes are responsible for transmission of malaria from human to mosquito. Artemisinin combination therapy (ACT) reduces post-treatment gametocyte carriage, dependent upon host, parasite and pharmacodynamic factors. The gametocytocidal properties of antimalarial drugs are important for malaria elimination efforts. An individual patient clinical data meta-analysis was undertaken to identify the determinants of gametocyte carriage and the comparative effects of four ACTs: artemether-lumefantrine (AL), artesunate/amodiaquine (AS-AQ), artesunate/mefloquine (AS-MQ), and dihydroartemisinin-piperaquine (DP). METHODS: Factors associated with gametocytaemia prior to, and following, ACT treatment were identified in multivariable logistic or Cox regression analysis with random effects. All relevant studies were identified through a systematic review of PubMed. Risk of bias was evaluated based on study design, methodology, and missing data. RESULTS: The systematic review identified 169 published and 9 unpublished studies, 126 of which were shared with the WorldWide Antimalarial Resistance Network (WWARN) and 121 trials including 48,840 patients were included in the analysis. Prevalence of gametocytaemia by microscopy at enrolment was 12.1 % (5887/48,589), and increased with decreasing age, decreasing asexual parasite density and decreasing haemoglobin concentration, and was higher in patients without fever at presentation. After ACT treatment, gametocytaemia appeared in 1.9 % (95 % CI, 1.7–2.1) of patients. The appearance of gametocytaemia was lowest after AS-MQ and AL and significantly higher after DP (adjusted hazard ratio (AHR), 2.03; 95 % CI, 1.24–3.12; P = 0.005 compared to AL) and AS-AQ fixed dose combination (FDC) (AHR, 4.01; 95 % CI, 2.40–6.72; P < 0.001 compared to AL). Among individuals who had gametocytaemia before treatment, gametocytaemia clearance was significantly faster with AS-MQ (AHR, 1.26; 95 % CI, 1.00–1.60; P = 0.054) and slower with DP (AHR, 0.74; 95 % CI, 0.63–0.88; P = 0.001) compared to AL. Both recrudescent (adjusted odds ratio (AOR), 9.05; 95 % CI, 3.74–21.90; P < 0.001) and new (AOR, 3.03; 95 % CI, 1.66–5.54; P < 0.001) infections with asexual-stage parasites were strongly associated with development of gametocytaemia after day 7. CONCLUSIONS: AS-MQ and AL are more effective than DP and AS-AQ FDC in preventing gametocytaemia shortly after treatment, suggesting that the non-artemisinin partner drug or the timing of artemisinin dosing are important determinants of post-treatment gametocyte dynamics

The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data

Background: Artemether-lumefantrine is the most widely used artemisinin-based combination therapy for malaria, although treatment failures occur in some regions. We investigated the effect of dosing strategy on efficacy in a pooled analysis from trials done in a wide range of malaria-endemic settings. Methods: We searched PubMed for clinical trials that enrolled and treated patients with artemether-lumefantrine and were published from 1960 to December, 2012. We merged individual patient data from these trials by use of standardised methods. The primary endpoint was the PCR-adjusted risk of Plasmodium falciparum recrudescence by day 28. Secondary endpoints consisted of the PCR-adjusted risk of P falciparum recurrence by day 42, PCR-unadjusted risk of P falciparum recurrence by day 42, early parasite clearance, and gametocyte carriage. Risk factors for PCR-adjusted recrudescence were identified using Cox's regression model with frailty shared across the study sites. Findings: We included 61 studies done between January, 1998, and December, 2012, and included 14 327 patients in our analyses. The PCR-adjusted therapeutic efficacy was 97·6% (95% CI 97·4-97·9) at day 28 and 96·0% (95·6-96·5) at day 42. After controlling for age and parasitaemia, patients prescribed a higher dose of artemether had a lower risk of having parasitaemia on day 1 (adjusted odds ratio [OR] 0·92, 95% CI 0·86-0·99 for every 1 mg/kg increase in daily artemether dose; p=0·024), but not on day 2 (p=0·69) or day 3 (0·087). In Asia, children weighing 10-15 kg who received a total lumefantrine dose less than 60 mg/kg had the lowest PCR-adjusted efficacy (91·7%, 95% CI 86·5-96·9). In Africa, the risk of treatment failure was greatest in malnourished children aged 1-3 years (PCR-adjusted efficacy 94·3%, 95% CI 92·3-96·3). A higher artemether dose was associated with a lower gametocyte presence within 14 days of treatment (adjusted OR 0·92, 95% CI 0·85-0·99; p=0·037 for every 1 mg/kg increase in total artemether dose). Interpretation: The recommended dose of artemether-lumefantrine provides reliable efficacy in most patients with uncomplicated malaria. However, therapeutic efficacy was lowest in young children from Asia and young underweight children from Africa; a higher dose regimen should be assessed in these groups. Funding: Bill and Melinda Gates Foundation